Welcome to Medical Laboratories, Zimbabwe’s premier provider of pathology testing services. With a rich history dating back to our establishment in 1985, we have grown from a single laboratory to a network of eight locations spanning the country.

At Medical Laboratories, we take pride in our extensive network, which includes branches, satellite laboratories, and collection points strategically located for your convenience. Our widespread presence allows us to serve a large number of patients and healthcare providers, catering to a significant volume of pathology tests performed in Zimbabwe.

We are dedicated to delivering accurate and reliable diagnostic services, utilising state-of-the-art technology and a team of highly skilled medical professionals. Whether you require routine blood work, specialised tests, or complex diagnostic procedures, we have you covered.

Main disciplines on offer include the following:

• Genomics

• Biochemistry

• Haematology

• Serology

• Microbiology

• Histology

• Cytology

Trusted and Accredited for Excellence
Medlabs was the first private laboratory in Zimbabwe to achieve ISO 15189 accreditation in 2014, a global standard for quality and competence in medical laboratories. This recognition reflects our commitment to accurate, reliable diagnostics that support better clinical outcomes. We are proud to have been reaccredited to the latest ISO 15189 standard, reinforcing our dedication to excellence.

Expertise That Delivers Excellence
Cimas Medlabs is staffed by qualified pathologists, scientists, technicians, phlebotomists and support teams dedicated to delivering seamless, high-quality laboratory services. Our professionals undergo continuous training to stay aligned with the latest advancements for the benefit of our patients.

The Future
Cimas Medlabs is enhancing specialised testing by localising services that were previously sent outside the country. A key focus is expanding our Genomics test portfolio, which helps clinicians use genetic insights to guide wellness, lifestyle, nutrition, metabolism, immunity, and disease risk. In response to rising cancer cases in Zimbabwe, Medlabs has acquired a state-of-the-art next-generation sequencing machine, enabling earlier detection and reducing the burden and mortality associated with cancer treatment.